ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Chiral Technologies acquires oligos firm Arbor Biosciences

by Rick Mullin
January 25, 2019 | APPEARED IN VOLUME 97, ISSUE 4

 

Seeking to expand its molecular biology services, Chiral Technologies, a division of Daicel specializing in enantioselective chromatography, will acquire Arbor Biosciences, a pharmaceutical services firm that generates oligonucleotide pools using massively parallel DNA synthesis technology. Arbor says it recently added a cell-free expression system using linear DNA as a template for rapid protein expression. Arbor, based in Ann Arbor, Michigan, will operate as a subsidiary of Daicel managed by Chiral Technologies.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment